GPR40 agonist (Liminal BioSciences)

N/A

Report date: 2025/03/20 14:48:14
NME

Base Information

Drug NameGPR40 agonist (Liminal BioSciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree fatty acid receptor 1 agonists
TargetsFree fatty acid receptor 1
Therapy Area/IndicationsInsulin ResistanceDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLiminal Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesLiminal Biosciences Inc
Inactive CompaniesN/A
Active IndicationsInsulin ResistanceDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A